Patents by Inventor Clarence J. Wang

Clarence J. Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100062002
    Abstract: To gain a better understanding of brain tumor angiogenesis, new techniques for isolating brain endothelial cells (ECs) and evaluating gene expression patterns were developed. When transcripts from brain ECS derived from normal and malignant colorectal tissues were compared with transcripts from non-endothelial cells, genes predominantly expressed in the endothelium were identified. Comparison between normal- and tumor-derived endothelium revealed genes that were specifically elevated in tumor-associated brain endothelium. These results confirm that neoplastic and normal endothelium in human brains are distinct at the molecular level, and have significant implications for the development of anti-angiogenic therapies in the future.
    Type: Application
    Filed: November 11, 2009
    Publication date: March 11, 2010
    Applicant: Genzyme Corporation
    Inventors: Stephen I. Madden, Clarence J. Wang, Brian P. Cook, John Laterra, Kevin Walter
  • Patent number: 5637683
    Abstract: The present invention relates to a nucleic acid analog having the formula: ##STR1## where R is a compound selected from a group consisting of hydrogen, a hydroxyl group, a hydrophilic group or a hydrophobic group,n is greater than or equal to 2, andBase is uracil, adenine, guanine, cytosine, thymine or hypoxanthine, with Bases in the analog being the same or different. Further, the present invention relates to a processes for making and using the analog.
    Type: Grant
    Filed: July 13, 1995
    Date of Patent: June 10, 1997
    Assignee: Cornell Research Foundation, Inc.
    Inventors: David A. Usher, Mark F. Harris, Clarence J. Wang